Details
| Stereochemistry | UNKNOWN |
| Molecular Formula | C13H14N2O2 |
| Molecular Weight | 230.2625 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 0 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1NC(CC2=C1NC3=C2C=CC=C3)C(O)=O
InChI
InChIKey=ZUPHXNBLQCSEIA-UHFFFAOYSA-N
InChI=1S/C13H14N2O2/c1-7-12-9(6-11(14-7)13(16)17)8-4-2-3-5-10(8)15-12/h2-5,7,11,14-15H,6H2,1H3,(H,16,17)
| Molecular Formula | C13H14N2O2 |
| Molecular Weight | 230.2625 |
| Charge | 0 |
| Count |
|
| Stereochemistry | MIXED |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 2 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
(1R,3S)-1-methyl-1,2,3,4-tetrahydro-β-carboline-3-carboxylic acid (MTCA) is a β-carboline indole alkaloid naturally occurring in plants, foods, insects, and endogenously in mammals and humans. It exerts antioxidant and antithrombotic properties. MTCA is thought to be a possible causative substance of eosinophilia-myalgia syndrome associated with ingestion of L-tryptophan.
CNS Activity
Sources: https://www.ncbi.nlm.nih.gov/pubmed/8517786
Curator's Comment: 1-Methyl-tetrahydro-beta-carboline-3-carboxylic acid (MTCA) is brain penetrant in rats. No human data available.
Originator
Sources: http://pubs.acs.org/doi/10.1021/jm00262a027
Curator's Comment: reference retrieved from https://www.ncbi.nlm.nih.gov/pubmed/6574460
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL204 Sources: https://www.ncbi.nlm.nih.gov/pubmed/27997749 |
0.39 µM [Ki] | ||
Target ID: CHEMBL244 Sources: https://www.ncbi.nlm.nih.gov/pubmed/27997749 |
0.43 µM [Ki] | ||
Target ID: CHEMBL1929 Sources: https://www.ncbi.nlm.nih.gov/pubmed/22957895 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | Unknown Approved UseUnknown |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Chemical Constituents from the Flower of Hosta plantaginea with Cyclooxygenases Inhibition and Antioxidant Activities and Their Chemotaxonomic Significance. | 2017-10-26 |
|
| Manipulation of the Precursor Supply in Yeast Significantly Enhances the Accumulation of Prenylated β-Carbolines. | 2017-06-16 |
|
| Inhibition of platelet aggregation and thrombosis by indole alkaloids isolated from the edible insect Protaetia brevitarsis seulensis (Kolbe). | 2017-06 |
|
| The Methyltetrahydro-{beta}-Carbolines in Maca (Lepidium meyenii). | 2009-09 |
|
| Increased level of tetrahydro-beta-carboline derivatives in short-term fermented garlic. | 2006-12 |
|
| Investigation of the tuber constituents of maca (Lepidium meyenii Walp.). | 2002-09-25 |
|
| Tetrahydro-beta-carbolines, potential neuroactive alkaloids, in chocolate and cocoa. | 2000-10 |
|
| 1-methyl-1,2,3,4-tetrahydro-beta-carboline-3-carboxylic acid and 1,2, 3,4-tetrahydro-beta-carboline-3-carboxylic acid in fruits. | 1999-12 |
|
| Accumulation of 1-methyl-tetrahydro-beta-carboline-3-carboxylic acid in blood and organs of rat. A possible causative substance of eosinophilia-myalgia syndrome associated with ingestion of L-tryptophan. | 1993 |
|
| Endogenous formation of 1-methyl-1,2,3,4-tetrahydro-beta-carboline-3- carboxylic acid in man as the possible causative substance of eosinophilia-myalgia syndrome associated with ingestion of L-tryptophan. | 1991 |
|
| Presence of 1-methyl-1,2,3,4-tetrahydro-beta-carboline-3-carboxylic acid, a precursor of a mutagenic nitroso compound, in soy sauce. | 1983-05 |
Patents
Sample Use Guides
rats: single oral dose 1.6 mg/kg or 10 mg/kg, chronic treatment with a 10 mg/kg dose for 6 weeks.
mice: 10-50 uM (iv)
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/27997749
(1R,3S)-1-methyl-1,2,3,4-tetrahydro-β-carboline-3-carboxylic acid treatment resulted in a dose-dependent inhibition of TNF-a-induced secretion of PAI-1 from HUVECs, which was significant at 10-50lM
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 11:21:45 GMT 2025
by
admin
on
Wed Apr 02 11:21:45 GMT 2025
|
| Record UNII |
667N6AT8F2
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Systematic Name | English | ||
|
Preferred Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
667N6AT8F2
Created by
admin on Wed Apr 02 11:21:45 GMT 2025 , Edited by admin on Wed Apr 02 11:21:45 GMT 2025
|
PRIMARY | |||
|
73530
Created by
admin on Wed Apr 02 11:21:45 GMT 2025 , Edited by admin on Wed Apr 02 11:21:45 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|